摘要
目的观察尤瑞克林治疗后循环短暂性脑缺血发作(TIA)的临床疗效。方法选择后循环TIA患者56例,随机分为治疗组(n=32)和对照组(n=24),在常规治疗的基础上,治疗组给予尤瑞克林0.15PNAU,每日一次,连用10天,观察临床症状改善情况和凝血五项、肝肾功能等化验指标的变化。结果两组疗效比较差异有显著统计学意义(P<0.05),治疗组疗效明显优于对照组。结论尤瑞克林治疗后循环TIA疗效肯定。
Objective To observe the clinical effect of urinary kallidinogenase in the treatment of patients with posterior cerebral circulation transient ischemic attack.Methods Fifty-six patients with posterior cerebral circulation transient ischemic attack were divided randomly into urinary kallidinogenase treatment group（32 cases） and control group（24 cases）.In addition to conventional treatment,urinary kallidinogenase was given additionally to the treatment group,0.15 PNAU daily for the consecutive 10 days.The progress of the disease,and the variation of the test indicators such as five items of blood coagulation,liver and kidney function,etc.were observed.Results There was significant difference between the two groups（P0.05）.The effectiveness in the treatment group was more marked than that in the control group.Conclusion Urinary kallidinogenase has an effect for treating patients with posterior cerebral circulation transient ischemic attack.
出处
《中国实用神经疾病杂志》
2013年第2期15-16,共2页
Chinese Journal of Practical Nervous Diseases
关键词
尤瑞克林
后循环短暂性脑缺血发作
疗效
Urinary kallidinogenase
Posterior cerebral circulation transient ischemic attack
